Korean Journal of Ophthalmology10.3341/kjo.2015.29.2.1152015292115Clinical Outcomes of Individualized Botulinum Neurotoxin Type A Injection Techniques in Patients with Essential BlepharospasmYoungje Sung, Sang Min Nam, Helen Lew,,
Toxins10.3390/toxins11010051201911151Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical FeaturesKazuya Yoshida
Scientific Reports10.1038/s41598-018-26750-5201881Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasmRen-Wen Ho, Po-Chiung Fang, Tsai-Ling Chao, Chun-Chih Chien, Ming-Tse Kuo,,
Clinical & Experimental Ophthalmology10.1111/j.1442-9071.2010.02303.x2010387688-691Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasmPaul S Cannon, Kenneth R MacKenzie, Anne E Cook, Brian Leatherbarrow,
Korean Journal of Ophthalmology10.3341/kjo.2017.003020183211Long-term Efficacy of Botulinum Neurotoxin-A Treatment for Essential BlepharospasmSeunghyun Lee, Sangrye Park, Helen Lew,,
Toxicon10.1016/j.toxicon.2018.11.0972018156S40Motor nerve sprouting and neuromuscular junction remodeling of orbicularis oculi muscles from patients with blepharospasm treated with botulinum neurotoxin type ABrigitte Girard, Aurélie Couesnon, Michel-Robert Popoff, Jordi Molgó,
Acta Ophthalmologica10.1111/aos.120022013912e108-e112Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasmDae Il Park, Hyun Min Shin, Sang Yeul Lee, Helen Lew
Clinical Parkinsonism & Related Disorders10.1016/j.prdoa.2022.10016020227100160Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystoniaRoongroj Bhidayasiri, Suppata Maytharakcheep, Daniel D. Truong,
Botulinum Toxin - Recent Topics and Applications10.5772/intechopen.1028962022Clinical Relevance of Neutralizing Antibodies in Botulinum Neurotoxin Type AHarald Hefter, Sara Samadzadeh
Clinical Applications of Botulinum Neurotoxin10.1007/978-1-4939-0261-3_4201495-121Clinical Use of Botulinum Neurotoxin: Autonomic ConditionsDirk Dressler